Portland — Portland, Oregon

Portland is a clinical research site located in Portland, Oregon, United States 97239.

Crixeo Health Trust Score: 71/100 (FAIR). This profile has not yet been claimed by the site owner.

Portland has participated in 5 clinical trials with 1 currently active.

Therapeutic areas: Clostridium Difficile Infection Recurrence, Metastatic Castration-Resistant Prostate Cancer, Clostridium Difficile Infection (CDI).

Sponsors: Finch Research and Development LLC., Corcept Therapeutics, Rebiotix Inc..

Sponsor Feasibility Report

Trust Score: 71/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Portland?

Portland has a Crixeo Trust Score of 71/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Portland conducted?

Portland has 5 clinical trials on record, with 1 currently active. Their work covers Clostridium Difficile Infection Recurrence, Metastatic Castration-Resistant Prostate Cancer, Clostridium Difficile Infection (CDI).

Is Portland accredited by Crixeo Health?

Yes — Portland holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Portland?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.